The FDA approved Eli Lilly and Company’s osteoporosis drug, Evista, to reduce the risk of invasive breast cancer
On Sept. 14, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved Eli Lilly’s osteoporosis…
On Sept. 14, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved Eli Lilly’s osteoporosis…
On Apr. 20, 2007, the National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007 allowed…
On Mar. 28, 2007, Magnetic Resonance Imaging (MRI) scans of women who were diagnosed with cancer in one…
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
On Nov. 11, 2005, the U.S. Congress authorized the 2-year extension of Postage Stamp for Breast Cancer Research…
On Jul. 10, 2003, the University Fertility Consultants at Oregon Health & Science University (OHSU) announced they had…
On Jun. 16, 2003, researchers at Stanford University Medical Center announced they found that a drug commonly prescribed…
On Jul. 17, 2002, A National Cancer Institute funded trial showed that postmenopausal women who used estrogen replacement…
On Nov. 12, 2001, the President George W. Bush signed P.L. 107-67 making appropriations for the Treasury Department,…
In 2001, the Regional Cancer Coalitions of Georgia were created by the General Assembly and Governor to ensure…
On Dec. 16, 2002, researchers at Stanford University Medical Center announced they were continuing a multi-year clinical trial…
On Jul. 28, 2000, President Bill Clinton signed into law the Semipostal Authorization Act (P.L. 106-253), which gave…
On Jun. 7, 2000, President Clinton issued an Executive Memorandum that directed the Medicare program to revise its…
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
On Sept. 14, 1998, researchers from the Breast Cancer Prevention Trial (BCPT) published a full report and update…
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
On Aug. 13, 1997, the Stamp Out Breast Cancer Act (PL 105-41) was signed into law by President…
In August 1997, the U.S. Congress passed legislation that directed the U.S. Postal Service to issue its first…
In 1997, planning began for Oregon Health & Science University’s (OHSU) Center for Women’s Health, and an interim…
In 1996, the National Cervical Cancer Coalition (NCCC), a growing coalition of people battling cervical cancer and HPV…
In 1995, Edward B. Lewis, Caltech graduate (Ph.D. 1942) and former faculty member, was awarded the Nobel Prize…
In 1994, the National Violence against Women Survey was created by the U.S. Centers for Disease Control and…
In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL…
On Oct. 27, 1992, the Mammography Quality Standards Act (MQSA) was passed (P.L. 102-539) by the U.S. Congress….
In December 1988, the National Cancer Institute (NCI) sponsored a workshop to address the standardization of cervical/vaginal cytopathology…
In 1973, clinicians at the Boston Hospital for Women, now part of Brigham and Womenï¾’s, developed noninvasive fetal…
In 1937, Johnsonï¾ &ï¾ Johnson established Ortho Research Laboratories in Linden, New Jersey, to make women’s health products.
In 1931, Johnson ï¾ & ï¾ Johnson pioneered family planning products with ORTHO-GYNOL, the first prescription contraceptive gel.
In 1915, Alice Ball became the first African American and the first woman to graduate with a M.S….
In 1913, the first known article on cancer’s warning signs was published in the popular women’s magazine (Ladies’…